UN panel recommends stricter patentability rules and compulsory licensing to improve access to medicine
A United Nations taskforce released its much-anticipated report on patient access to medicines this week. In the run-up to the report’s publication, many IP owners expected that the role of patents in the drug industry would very much be in the…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.